These findings mirrored results from conditional MYC+;Pten-mutant;Tp53-mutant transgenic mice, where stepwise alterations in MYC, Pten and Tp53 led to the development of advanced cancer [11, 12]. The gene discussed is TP53; the disease is cancer.